When was Qilu Pharmaceutical Group founded?

Qilu Pharmaceutical Group was founded in 1958.

Where is Qilu Pharmaceutical Group located?

Qilu Pharmaceutical Group is headquartered in Jinan, China.

How many employees does Qilu Pharmaceutical Group have?

As of Mar 31, 2026, the latest employee count at Qilu Pharmaceutical Group is 243.

Is Qilu Pharmaceutical Group a funded company?

Qilu Pharmaceutical Group is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Qilu Pharmaceutical Group rank among its competitors?

Qilu Pharmaceutical Group ranks 35th amongst 1030 active competitors, of which 41 are funded.

Who are the top competitors of Qilu Pharmaceutical Group?

Qilu Pharmaceutical Group's top competitors include Laurus Labs, Neuland and NGL Fine Chem.

Qilu Pharmaceutical Group - 2026 Company Profile, Team, Funding & Competitors

Company Details

Qilu Pharmaceutical develops and manufactures APIs and intermediates (sterile and non-sterile). The products are of various therapeutic categories including oncology, cardiovascular, cerebrovascular, antiinfective, psychiatric, and ophthalmic diseases. They export their products to Australia, North America, Japan, and U.K.

Website: www.qilu-pharma.com
Social
Email ID: *****@qilu-pharma.com
Phone Number: +86 **********

Key Metrics

Founded Year

1958

Location

Jinan, China

Stage

Funding Raised

Investors

Yijing Capital

Ranked

35^th among 1030 active competitors

Employee Count

243 as on Mar 31, 2026

Investment & Acquisitions

Arbutus Bio & 1 more

Similar Companies

Laurus Labs & 1249 more

View Qilu Pharmaceutical Group's full profile

Qilu Pharmaceutical Group is a funded company. Qilu Pharmaceutical Group has 1 institutional investor.

View details of Qilu Pharmaceutical Group's funding rounds and investors

The founders of Qilu Pharmaceutical Group is Xiayang Qiu. Xiayang Qiu is the CEO of Qilu Pharmaceutical Group.

Here are the details of Qilu Pharmaceutical Group's key team members:

Xiayang Qiu: Founder & CEO of Qilu Pharmaceutical Group.

View details of Qilu Pharmaceutical Group's Founder profiles and Board Members

Qilu Pharmaceutical Group's employee count trend

Qilu Pharmaceutical Group has 243 employees as of Mar 26. Here is Qilu Pharmaceutical Group's employee count trend over the years:

Employee count trend for Qilu Pharmaceutical Group

Uncover Qilu Pharmaceutical Group's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Qilu Pharmaceutical Group include Laurus Labs, Neuland and NGL Fine Chem. Here is the list of Top 10 competitors of Qilu Pharmaceutical Group, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	Warburg Pincus, F-Prime Capital & 3 others	69/100
2nd	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	InvAscent, India Capital Growth & 1 others	61/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	57/100
4th	Provepharm Life Solutions 1998, Marseille (France), Late Stage	Pharmaceutical company dedicated towards the development and valorization of APIs and drug Products	$146M	Societe Generale, BNP Paribas & 9 others	54/100
5th	Sms Pharmaceuticals 1990, Hyderabad (India), Public	Traditional pharmaceutical company manufacturing active pharmaceutical ingredients (API)	-	-	53/100
6th	Symbiotec 2002, Indore (India), Acquired	CDMO focused on manufacturing of non sterile steroid-hormone based APIs and intermediates	$61M	Actis, Franklin Templeton Investments & 20 others	53/100
7th	Sterling Pharma Solutions 2016, Dudley (United Kingdom), Acquired	CDMO offering contract development, manufacturing and analytical services for APIs	-	Partners Group, GHO Capital Partners	52/100
8th	Beijing Biostar Technologies 2002, Beijing (China), Public	Developer and manufacturer of APIs, intermediates, & biochemical reagents	$135M	Fortune Capital, Detong Capital & 9 others	52/100
9th	Uquifa 1936, Barcelona (Spain), Acquired	Traditional company manufacturing APIs and intermediates	$42.5M	Orbimed, InvAscent & 1 others	51/100
10th	Divis Laboratories 1990, Hyderabad (India), Public	Manufacturer of APIs, intermediates, and building blocks of peptides and nucleotides	-	India Capital Growth	50/100
35th	Qilu Pharmaceutical Group 1958, Jinan (China), Funding Raised	Developer and manufacturer of APIs and intermediates	-	Yijing Capital	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Qilu Pharmaceutical Group's competitors? Click here to see the top ones

Qilu Pharmaceutical Group has made 2 investments in Arbutus Bio and Regor. Qilu Pharmaceutical Group has not made any acquisitions as of now.

Here is the latest report on Qilu Pharmaceutical Group's sector:

Free

Biopharma Outsourcing - Sector Report

Edition: May, 2025 (85 Pages)

View all reports related to Qilu Pharmaceutical Group

Media has covered Qilu Pharmaceutical Group for a total of 6 events in the last 1 year, 4 of them have been about partnerships and 1 about company updates.